In Europe, 1–3% of the population suffers from atrial fibrillation (AF) and has increased
stroke risk. By 2060 a doubling in number of cases and great burden in managing this …

Background Atrial fibrillation (AF) increases the risk of develo** a stroke by 20%. AF
related strokes are associated with greater morbidity. Historically, warfarin was the …

Background Adherence to guidelines pertaining to stroke prevention in patients with atrial
fibrillation is poor. Decision support systems have shown promise in increasing guideline …

Background: Bleeding is commonly cited as a reason for stop** oral anticoagulants
(OACs). Whether minor bleeding events (nuisance bleeding, NB) in patients with atrial …

Background Clinical decision support systems (CDSS) have been utilized as a low-cost
intervention to improve healthcare process measures. Thus, we aim to estimate CDSS …

Atrial fibrillation (AF) and cancer are common disorders in the general population but there
are few studies in patients with both diseases. More specifically, there are scarce data on AF …

Background and objectives Most of the French patients diagnosed with atrial fibrillation (AF)
are managed by general practitioners (GPs). The objective was to evaluate stroke …

Background: In suspected hypercortisolism, the 1 mg dexamethasone suppression test is
the usual initial test. In fertile women, false-positive test results are often due to the use of …

Nonvalvular atrial fibrillation (AF) is the most widespread cardiac arrhythmia of clinical
significance worldwide, and its prevalence is increasing. 1, 2 Atrial fibrillation is a substantial …

Summary Background General practitioners (GPs) play a pivotal role in the long-term
management of patients with atrial fibrillation (AF), including anticoagulant prophylaxis for …